Triple negative breast cancer: current understanding of biology and treatment options
作者： Soonmo Peter Kang , Maritza Martel , Lyndsay N Harris
DOI: 10.1097/GCO.0B013E3282F40DE9
关键词: Oncology 、 Basal-Like Breast Cancer 、 Internal medicine 、 Breast cancer 、 Triple-negative breast cancer 、 Triple negative 、 Poor prognosis 、 Medicine 、 Treatment options 、 Obstetrics and gynaecology
摘要: Purpose of reviewWe have made remarkable advances in treatment breast cancer with combination chemotherapies, hormonal therapies, and modern targeted therapies. Triple negative cancers carry a poor prognosis, however, they are insensitive to most available or therapeu
sci-hub.se 参考文章(71)
T. Petit, M. Wilt, J. Rodier, D. Muller, J. Ghnassia, P. Dufour, J. Fricker, Are BRCA1 mutations a predictive factor for anthracycline-based neoadjuvant chemotherapy response in triple-negative breast cancers? Journal of Clinical Oncology. ,vol. 25, pp. 580- 580 ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.580
Ralph Scully, David M. Livingston, In search of the tumour-suppressor functions of BRCA1 and BRCA2 Nature. ,vol. 408, pp. 429- 432 ,(2000) , 10.1038/35044000
Nicholas Turner, Andrew Tutt, Alan Ashworth, Hallmarks of 'BRCAness' in sporadic cancers Nature Reviews Cancer. ,vol. 4, pp. 814- 819 ,(2004) , 10.1038/NRC1457
Dominique Stoppa-Lyonnet, Yan Ansquer, Hélène Dreyfus, Chantal Gautier, Marion Gauthier-Villars, Edwige Bourstyn, Krishna B. Clough, Henri Magdelénat, Pierre Pouillart, Anne Vincent-Salomon, Alain Fourquet, Bernard Asselain, Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations Journal of Clinical Oncology. ,vol. 18, pp. 4053- 4059 ,(2000) , 10.1200/JCO.2000.18.24.4053
G M Clark, C K Osborne, W L McGuire, Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. Journal of Clinical Oncology. ,vol. 2, pp. 1102- 1109 ,(1984) , 10.1200/JCO.1984.2.10.1102
C Jones, A V Nonni, L Fulford, S Merrett, R Chaggar, V Eusebi, S R Lakhani, CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. British Journal of Cancer. ,vol. 85, pp. 422- 427 ,(2001) , 10.1054/BJOC.2001.1869
Early Breast Cancer Trialists' Collaborative Group, None, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials The Lancet. ,vol. 365, pp. 1687- 1717 ,(2005) , 10.1016/S0140-6736(05)66544-0
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, M. J. Thun, Cancer statistics, 2007. CA: A Cancer Journal for Clinicians. ,vol. 57, pp. 43- 66 ,(2007) , 10.3322/CANJCLIN.57.1.43
S Banerjee, Basal-like breast carcinomas: clinical outcome and response to chemotherapy Journal of Clinical Pathology. ,vol. 59, pp. 729- 735 ,(2006) , 10.1136/JCP.2005.033043
Hannah Farmer, Nuala McCabe, Christopher J. Lord, Andrew N. J. Tutt, Damian A. Johnson, Tobias B. Richardson, Manuela Santarosa, Krystyna J. Dillon, Ian Hickson, Charlotte Knights, Niall M. B. Martin, Stephen P. Jackson, Graeme C. M. Smith, Alan Ashworth, Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature. ,vol. 434, pp. 917- 921 ,(2005) , 10.1038/NATURE03445